Skip over navigation | Sla menu over


Recent news

ProteoNic Licenses Technology to Eli Lilly and Co.
5 Feb 2019 Recent news proteonicnl proteonicnl

ProteoNic Biotechnology BV announces that it licensed its 2G UNic™ technology for boosting recombinant protein production to Eli Lilly and Company.

Under the agreement, Lilly gains non-exclusive commercial rights for application of the technology to the development of proprietary products. Financial details of the agreement were not disclosed.

1 item